D-0596-2024 Class III
FDA drug recall D-0596-2024 was initiated by Zydus Pharmaceuticals (USA) Inc on Jul 2, 2024 and is designated Class III. Reason for recall: Cross contamination with other products
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 17, 2024
- Initiation Date
- Jul 2, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, NDC 16714-301-01 (vial), NDC 16714-301-10 (outer box).
Reason for Recall
Cross contamination with other products
Distribution Pattern
Nationwide in the USA and Puerto Rico
Code Information
Lot #: L300217, Exp. 04/31/2025.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0596-2024
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026